Skip to main content

AstraZeneca signals beyond the news: 53+ signals from 7 sources

The latest AstraZeneca signal on this page is from Nov 17, 2026 (Patents): "AstraZeneca AB's patent output is slowing: 34 grants in the past year, 2 in the past 30 days." The busiest sources: Website changes (15+), X (Twitter) (12) and Patents (10).

PublicPharmaceutical Manufacturing10,000+ employeesastrazeneca.comLinkedIn

Get AstraZeneca's live signals in Claude or ChatGPT, or by API

AskWhat changed at AstraZeneca this week? Use Autobound signals for astrazeneca.com.
Signals
53+
Sources
7
Last 90 days
33
Latest
Nov 17, 2026

Source: Autobound Signal API · 84 signals tracked for AstraZeneca · updated

Other signals · latest 10

Latest AstraZeneca signals by source

53+ signals for AstraZeneca across 7 sources.

  1. Patents · Patent pace

    AstraZeneca AB's patent output is slowing: 34 grants in the past year, 2 in the past 30 days.

    Over the past year AstraZeneca AB received 34 US patent grants, concentrated in image processing / graphics and software / computing; the recent pace (10 in 90 days) is slowing versus its trailing baseline.

    Grants, 12 months
    34
    Grants, 90 days
    10
    Grants, 30 days
    2
    Pace
    Decelerating

    Google Patents

  2. Reddit · Layoffs

    AstraZeneca is cutting approximately 600 jobs from its U.S.

    Post: "AstraZeneca is cutting about 600 jobs from its U.S. respiratory and immunology commercial teams"

    Subreddit
    r/biotech
    Upvotes
    145
    Comments
    20
    Sentiment
    Negative

    r/biotech

  3. Patents · Patent grant

    AstraZeneca was granted a patent for CDK2-targeting drug compounds.

    In November 2026 AstraZeneca patented purine-based medicines intended to treat or prevent CDK2-related conditions, for use in pharmaceutical treatment and research.

    Patent title
    2,6,9-trisubstituted purines
    Grant date
    Nov 10, 2026
    Inventors
    Bernard Barlaam, Michael Bodnarchuk, Avipsa Ghosh, Frederick Goldberg

    Google Patents

  4. X (Twitter)

    AstraZeneca ranks top three in 2026 Access to Medicine Index, targets 400 million people by 2030.

    We're proud to be recognised among the top 3 in the 2026 Access to Medicine Index. By 2030, we aim to reach 400 million people from underserved communities with our medicines and Health Equity programmes. Read more about our results: https://t.co/pruw4DmDZ7 @AtMIndex #HealthEquity #ATMIndex10 #AccessToMedicine

    Account
    @AstraZeneca
    Views
    5,345
    Likes
    10
    Reposts
    2

    X (@AstraZeneca)

  5. Reddit · Layoffs

    Reddit commenters interpret AstraZeneca's announced $2 billion restructuring programme as a precursor to impending workforce layoffs.

    Post: "AstraZeneca announces $2bn restructuring to invest in drugs pipeline"

    Subreddit
    r/biotech
    Upvotes
    132
    Comments
    37
    Sentiment
    Negative

    r/biotech

  6. X (Twitter)

    AstraZeneca releases 9M and Q3 2026 results, reporting total revenue up 7%.

    For #Investors and #Media only. Our 9M and Q3 2026 results are now available, highlighting continued strong commercial performance, with Total Revenue up 7%. Learn more: https://t.co/l2XUX5F4cO #AZN #FinancialResults $AZN https://t.co/YB9mEbSR2f

    Account
    @AstraZeneca
    Views
    4,558
    Likes
    13
    Reposts
    2

    X (@AstraZeneca)

  7. Podcasts · Tech adoption

    Supercomputing in Europe discusses AstraZeneca: tech adoption

    "one of my kind of proudest moment for my own software that I'm part of the development of, which is the quantum chemistry software is that AstraZeneca has adopted Veloxchem as a main vehicle for the research in M"

    Podcast
    Supercomputing in Europe
    Episode
    The importance of scientific software development - Patrick Norman
    Speaker
    Patrick Norman
    Speaker role
    Counterparty

    Supercomputing in Europe

  8. Website changes · Product update

    The investor-relations page replaced the 2026 post-quarter aide memoire link with a 2026 pre-quarter aide memoire link and removed the H1 and Q2 2026 results link from the latest aide memoire section.

    Removed “AZN-PostQ2-Aide-memoire-2026.pdf” and added “AZN-PreQ3-Aide-memoire-2026.pdf”; removed “H1 and Q2 2026 results” from the latest aide memoire list.

    Page
    /investor-relations.html

    astrazeneca.com

  9. Conference talks

    Haydyn Phillips (Director of User Experience (UX) - Enterprise UX strategy & Operations, AstraZeneca) at UXDX EMEA 2026.

    Conference
    UXDX EMEA 2026
    Date
    May 27, 2026
    Location
    Berlin and Online
    Topics
    user research, engineering, developer experience, user experience

    UXDX EMEA 2026

  10. LinkedIn

    Understanding the genetic differences that make each of us unique is helping uncover new biology - informing R&D and guiding drug discovery.

    Understanding the genetic differences that make each of us unique is helping uncover new biology - informing R&D and guiding drug discovery. At our Centre for Genomics Research, we study these genetic differences on a global scale. As our data grows, so does our commitment to open, sustainable science - ensuring...

    Likes
    158
    Comments
    8
    Tags
    Medical Research, Pharmaceuticals, Research & Development, Big Data

    LinkedIn

Showing 10 of 53+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track AstraZeneca with the Signal API

One POST /v1/companies/enrich call with astrazeneca.com returns AstraZeneca signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "astrazeneca.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about AstraZeneca other signals

What signals does Autobound track for AstraZeneca besides news and filings?
This page lists 53+ signals for AstraZeneca from 7 sources: Website changes (15+), X (Twitter) (12), Patents (10), LinkedIn (7), Reddit (4), Podcasts (3) and Conference talks (2). Every row is dated, and most link to the post, review or record.
What are people saying about AstraZeneca online?
The newest posts on this page: Nov 14, 2026, Reddit (r/biotech): AstraZeneca is cutting approximately 600 jobs from its U.S. Nov 10, 2026, X (Twitter) (X (@AstraZeneca)): AstraZeneca ranks top three in 2026 Access to Medicine Index, targets 400 million people by 2030. Oct 30, 2026, Reddit (r/biotech): Reddit commenters interpret AstraZeneca's announced $2 billion restructuring programme as a precursor to impending workforce layoffs.
Has AstraZeneca been granted patents recently?
Yes. The newest grant on this page: Nov 10, 2026, Patents (Google Patents): AstraZeneca was granted a patent for CDK2-targeting drug compounds.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →